Regeneron Pharmaceuticals Newsroom

Implied Volatility Surging for Regeneron Pharmaceuticals (REGN) Stock Options

Yahoo FinanceJan 28 21:46

Beyond The Numbers: 18 Analysts Discuss Regeneron Pharmaceuticals Stock

BenzingaJan 28 21:00

Citi Maintains Regeneron Pharmaceuticals(REGN.US) With Hold Rating, Cuts Target Price to $750

Futu NewsJan 28 20:34 · Ratings

Citigroup Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $795, Maintains Neutral Rating

MT NewswiresJan 28 19:23 · Ratings

Express News | Regeneron Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $762 From $800

BreakingsJan 28 19:03

Drug Companies Raise Prices on More Than 800 Drugs in January -- WSJ

WSJJan 28 18:30

Regeneron Pharma Is Maintained at Overweight by Piper Sandler

Dow JonesJan 27 23:07 · Ratings

Today's Analyst Rating | NVIDIA Price Target Raised to $200 by Cantor Fitzgerald, Alphabet-C Price Target Raised to $225 by Needham

Jan 27, Wall Street analysts have updated their stock ratings today including $NVIDIA(NVDA.US)$ and $Alphabet-C(GOOG.US)$.

Futu NewsJan 27 21:00 · Ratings

Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,013

Futu NewsJan 27 20:34 · Ratings

Looking Into Regeneron Pharmaceuticals's Recent Short Interest

BenzingaJan 24 22:00

Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Falling Stock to Invest in Right Now?

Yahoo FinanceJan 24 20:38

Express News | America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search

BreakingsJan 24 01:00

America's Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search

GlobeNewswireJan 24 01:00

RBC Capital Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,059

Futu NewsJan 23 10:32 · Ratings

RBC Adjusts Price Target on Regeneron Pharmaceuticals to $1,059 From $1,184, Maintains Outperform Rating

MT NewswiresJan 22 21:23 · Ratings

Morgan Stanley Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,185

Futu NewsJan 21 21:31 · Ratings

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): 'This Company Has Never Lost Its Ability To Develop New Medicines'

Yahoo FinanceJan 19 19:17

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

BenzingaJan 16 23:30

Express News | Regeneron Pharmaceuticals Inc : UBS Cuts to Neutral From Buy

BreakingsJan 16 19:41

UBS Downgrades Regeneron Pharmaceuticals(REGN.US) to Hold Rating, Cuts Target Price to $738

Futu NewsJan 16 18:33 · Ratings